Header cover image
  • Investing Ideas
  • Japanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Japanese Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Sumitomo Pharma

Market Cap: JP¥667.1b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

4506

JP¥1,487.00

7D

1.7%

1Y

45.5%